Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,837
Closed -$217K 387
2022
Q3
$217K Sell
1,837
-130
-7% -$19.7K 0.03% 346
2022
Q2
$281K Buy
1,967
+44
+2% +$6.29K 0.04% 313
2022
Q1
$331K Buy
1,923
+533
+38% +$89.7K 0.04% 304
2021
Q4
$353K Buy
+1,390
New +$406K 0.04% 305

Other funds holding MRNA

Intrust Bank's MRNA Position: Q4 2022 in Review

Intrust Bank sold out of Moderna (MRNA) in Q4 2022, closing a stake of 1,837 shares — an estimated $217K sold.

Intrust Bank first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $353K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Intrust Bank reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Intrust Bank sold 1,837 Moderna shares in Q4 2022, an estimated $217K.
  • Intrust Bank first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • Intrust Bank's Moderna position peaked at $353K in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Intrust Bank's 13F filing for Q4 2022, filed 10 Feb 2023.